Vera Therapeutics Earnings
NASDAQ: VERAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.72
Vera Therapeutics earnings summary
Vera Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.72. In its most recent report on Aug 10, 2026 (Q2 2026), VERA posted EPS of $-1.52. Across the last 16 reports, VERA shares moved an average of 6.8% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
VERA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 10, 2026 | — | $-1.52 | — | +2.0% |
| May 7, 2026 | — | $-1.69 | — | +3.1% |
| Feb 26, 2026 | — | $-1.39 | — | -4.2% |
| Nov 5, 2025 | — | $-1.26 | — | +17.2% |
| Aug 5, 2025 | — | $-1.20 | — | +8.8% |
| May 7, 2025 | — | $-0.81 | — | -2.1% |
| Feb 28, 2025 | — | $-0.72 | — | -3.7% |
| Nov 7, 2024 | — | $-0.85 | — | -3.8% |
| Aug 8, 2024 | — | $-0.62 | — | +4.6% |
| May 10, 2024 | — | $-0.56 | — | +0.2% |
| Mar 27, 2024 | — | $-0.54 | — | -13.0% |
| Nov 9, 2023 | — | $-0.45 | — | +12.8% |
| Aug 10, 2023 | — | $-0.46 | — | -7.0% |
| May 11, 2023 | — | $-0.80 | — | +3.8% |
| Mar 28, 2023 | — | $-1.18 | — | -21.3% |
| Nov 9, 2022 | — | $-0.91 | — | -0.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.